Moderna's flu vaccine faces FDA setback, stock dips on regulatory hurdles. Valuation concerns rise.
BTC tests $66K, below 200-week EMA. ETH, XRP, DOGE also drop. Bearish target $52K.
AMAT eyes new highs despite sales dip; options hint at 6% move. Up 80% YOY!
US jobs data shows sluggish hiring, with ~55K jobs expected in Jan. Revisions may show near-zero growth for 2025.
EU tariffs on Chinese EVs range from 7.8% to 35.3%, but some models like Cupra's Tavascan get exemptions.
Moderna shares drop 9% as FDA rejects flu vaccine review, hitting revenue goals. Risks rise.
Arkham Exchange shutters amid low volumes, its ARKM token trades near $0.12.
Must Read